搜索筛选:
搜索耗时2.5334秒,为你在为你在102,285,761篇论文里面共找到 8 篇相符的论文内容
类      型:
[期刊论文] 作者:Ya-Feng Li,Yan-Li Wang,Si-Hai, 来源:中国动脉硬化杂志 年份:2013
[期刊论文] 作者:Yang Bao,SHI Ya-feng,LI Heng-p, 来源:中国地理科学 年份:2004
A compilation of paleoclimate records from ice core, tree-rings, lake sediments and historical documents provides a view of temperature change in China over the...
[期刊论文] 作者:WEN Li-Rong,QI Wen-Ying,LI Ya-Feng,LI Ming,SUN En-Tao, 来源:黑龙江科技信息 年份:2007
本文通过对荣华二采区10...
[期刊论文] 作者:Ya-Feng Li,Ying Jing,Jielu Hao,Nathan C Frankfort,Xiaoshuang Zhou,Bing Shen,Xinyan Liu, 来源:蛋白质与细胞 年份:2013
[期刊论文] 作者:Gu Cheng-Yan,Liu Gui-Peng,Shi Kai,Song Ya-Feng,Li Cheng-Ming,Liu Xiang-Lin,Yang Shao-Yan,Zhu Qin-Sheng, 来源:中国物理B(英文版) 年份:2012
[会议论文] 作者:Ya-Feng Li,Yan-Li Wang,Si-Hai Zhao,Rui-Han Liu,Yu-Long Chen,Yan Lin,Ning-Hong Zhu,Liang Bai,Jiang-Lin, 来源:第十二次全国动脉硬化性疾病学术会议 年份:2013
Objective Urotensin Ⅱ (U Ⅱ) is a vasoactive peptide of 11 amino acids, and may contribute to the development of atherosclerosis.The purpose of this study was to investigate whether U Ⅱ can promote the...
[会议论文] 作者:Yan-Li Wang,Ya-Feng Li,Rui-Han Liu,Yu-Long Chen,Yan Lin,Ning-Hong Zhu,Si-Hai Zhao,Liang Bai,Jiang-Lin, 来源:第十二次全国动脉硬化性疾病学术会议 年份:2013
Background and Aim Lipid-lowering therapy is the major choice for the treatment and prevention of cardiovascular diseases Although statins are widely used in clinic, many patients with cardiovascular...
[期刊论文] 作者:Qing-qing Yu,Da-xin Cheng,Li-ran Xu,Yan-kui Li,Xiao-ya Zheng,Yi Liu,Ya-feng Li,Hao-le Liu,Liang Bai,Rong, 来源:中国药理学报(英文版) 年份:2020
Increasing levels of plasma urotensin Ⅱ (UⅡ) are positively associated with atherosclerosis.In this study we investigated the role of macrophage-secreted UⅡ...
相关搜索: